Dechra Pharmaceuticals (DPH)

 

Latest News

Total Voting Rights

RNS Number: 9739X Dechra Pharmaceuticals PLC 30 November 2017 30 November 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Total Voting Rights In conformity with DTR 5.6.1R, the Company notifies the market of the following: As at the date of this announcement, the Company's issued share capital consists of 93...

Total Voting Rights

RNS Number: 1204V Dechra Pharmaceuticals PLC 31 October 2017 31 October 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Total Voting Rights In conformity with DTR 5.6.1R, the Company notifies the market of the following: As at the date of this announcement, the Company's issued share capital consists of 93,415,750...

Result of AGM - 20 October 2017

RNS Number: 2365U Dechra Pharmaceuticals PLC 20 October 2017 Date: 20 October 2017 Dechra Pharmaceuticals PLC Results of Annual General Meeting (AGM) AGM Meeting Date: 1pm on 20 October 2017 Issued Share Capital at meeting date: 93,415,750 Number of shareholders in attendance: 12 All resolutions were passed on a show of hands. Details of the proxy v...

Top smaller companies thriving overseas

Two top fund managers tell David Brenchley about their favourite small and mid-cap companies as they rotate out of UK...

All News

DateHeadlineSource
26-02-15City loves small-cap pharmaInteractive Investor
23-02-15Dechra Pharmaceuticals underlying operating profits up StockMarketWire
23-02-15Dechra Pharmaceutical - Half year financial report 2015BRR Media
09-02-15How to value drug company management teamsInteractive Investor
15-01-153 Fast-Growing Pharmaceuticals Set To Outperform: Shire PLC, BTG plc and Dechra Pharmaceuticals plcMotley Fool
14-01-15Dechra maintains momentum StockMarketWire
13-11-14Share Sleuth's November WatchlistMoney Observer
24-10-14Dechra in line with management expectationsStockMarketWire
15-09-14Dechra results bear out strategyRichard Beddard
08-09-14Dechra underlying pre-tax profits upStockMarketWire
08-09-14Dechra Pharmaceuticals - Preliminary Results for year ended 30 June 2014BRR Media
08-07-14Dechra in lineStockMarketWire
08-07-14Dechra revenues upStockMarketWire
20-05-14Dechra strengthens its US product portfolioStockMarketWire
02-05-14Dechra gets FDA and VMD approvalsStockMarketWire
30-04-14Dechra revenues upStockMarketWire
03-03-14Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
03-03-14Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
25-02-14Dechra underlying operating profits jumpStockMarketWire
29-01-14Dechra director leaves after board shake-upStockMarketWire
13-01-14Dechra operating profits in line with forecastsStockMarketWire
13-01-14Dechra on track despite weak NetherlandsStockMarketWire
08-01-14Four small-cap stocks for 2014 and beyond - part oneInteractive Investor
03-12-13Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
06-11-13Share Sleuth's November WatchlistMoney Observer
23-10-13Animalcare: enhancing medicines to enhance profitsRichard Beddard
22-10-13CVS, the veterinary group that does everythingRichard Beddard
18-10-13Dechra resolutions passed at AGMStockMarketWire
17-10-13Dechra SID retires StockMarketWire
17-10-13Dechra trading in line with forecastsStockMarketWire
07-10-13Dechra is animal pharmaceuticals pureplayRichard Beddard
03-09-13Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
03-09-13Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
03-09-13Dechra underlying pre-tax profits upStockMarketWire
03-09-13What's in store today...Interactive Investor
30-08-13The week ahead...Interactive Investor
16-08-13Dechra completes sale of services segment StockMarketWire
26-07-13Best green funds balance ethics with resultsMoney Observer
10-07-13Dechra revenues up 19%StockMarketWire
10-07-13Dechra to sell services segment for £87.5mStockMarketWire

RSS feeds

  • Editorial news feed for LSE:DPH Editorial
  • Regulatory news feed for LSE:DPH Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account